Growth Metrics

Pfizer (PFE) Change in Intangibles (2016 - 2020)

Pfizer has reported Change in Intangibles over the past 8 years, most recently at $38.0 million for Q3 2020.

  • Quarterly Change in Intangibles fell 60.82% to $38.0 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $125.0 million through Sep 2020, down 73.35% year-over-year, with the annual reading at $539.0 million for FY2020, 28.95% up from the prior year.
  • Change in Intangibles was $38.0 million for Q3 2020 at Pfizer, up from $1.0 million in the prior quarter.
  • Over five years, Change in Intangibles peaked at $158.0 million in Q1 2019 and troughed at $1.0 million in Q2 2020.
  • The 5-year median for Change in Intangibles is $76.5 million (2016), against an average of $74.1 million.
  • Year-over-year, Change in Intangibles surged 1820.0% in 2016 and then crashed 99.08% in 2020.
  • A 5-year view of Change in Intangibles shows it stood at $80.0 million in 2016, then dropped by 8.75% to $73.0 million in 2017, then soared by 43.84% to $105.0 million in 2018, then tumbled by 48.57% to $54.0 million in 2019, then fell by 29.63% to $38.0 million in 2020.
  • Per Business Quant, the three most recent readings for PFE's Change in Intangibles are $38.0 million (Q3 2020), $1.0 million (Q2 2020), and $32.0 million (Q1 2020).